A methodological framework for drug development in rare diseases. The CRESim program: Epilogue and perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A methodological framework for drug development in rare diseases. The CRESim program: Epilogue and perspectives

Published:2020-04 Issue:2 Volume:75 Page:149-156
ISSN:0040-5957
Container-title:Therapies
language:en
Short-container-title:Therapies

Author:

Nony Patrice,Kassai Behrouz,Cornu Catherine

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference54 articles.

1. The cost of drug development: a systematic review;Morgan;Health Policy (New York),2011

2. Innovation in the pharmaceutical industry: new estimates of R&D costs;DiMasi;J Health Econ,2016

3. Examination of clinical trial costs and barriers for drug development | ASPE;Assistant Secretary of Planning and Evaluation (ASPE),2014

4. Modelling methodology in physiopathology;Boissel;Prog Biophys Mol Biol,2008

5. Clinical trial simulation: a review;Holford;Clin Pharmacol Ther,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Achieving big with small: quantitative clinical pharmacology tools for drug development in pediatric rare diseases;Journal of Pharmacokinetics and Pharmacodynamics;2023-05-04

2. Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health;BMJ Evidence-Based Medicine;2023-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP